THE ASSOCIATION BETWEEN ADIPONECTIN, LEPTIN, PROINFLAMMATORY MARKERS AND METABOLIC SYNDROME IN OBESE, NONDIABETIC SUBJECTS

Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 2

Abstract

The aim of this study was to evaluate the association between adipokines (adiponectin and leptin), inflammatory markers, insulin resistance and metabolic syndrome in obese, non-diabetic subjects. Methods: Thirty three obese patients (19 men and 14 women) with metabolic syndrome (MetS) defined according IDF criteria, twenty three obese patients (12 men and 11 women) without MetS and eighteen controls (9 men and 9 women) lean subjects without MetS were included. In all individuals were assessed MetS components as well as serum levels of adiponectin, leptin, high sensitive C-reactive protein (hs-CRP), insulin, fibrinogen and leukocyte count (WBC). Results: In both sexes, obese subjects with MetS, compared to obese subjects without MetS had significantly higher systolic blood pressure (SBP), diastolic blood pressure (DBP), HOMA-IR, WBC, plasma concentrations of hs-CRP, leptin, triglyceride and fibrinogen and significantly lower concentration of HDL-cholesterol. A significantly lower concentration of adiponectin and a higher concentration of fasting insulin were observed in obese men with MetS compared to obese men without MetS. In all study subjects adiponectin was negatively correlated with BMI, body fat, triglyceride, HOMA-IR and positively correlated with HDL-cholesterol and hs-CRP was positively correlated with BMI, waist, body fat, triglyceride, HOMA-IR and negatively correlated with HDL-cholesterol. Hs-CRP was positively correlated with leptin in obese women and negatively correlated with adiponectin in obese men. Conclusions: In obese, non-diabetic subjects adiponectin, leptin, proinflammatory state and prothrombotic state are strongly correlated with MetS. Obese subjects with MetS had higher levels of hs-CRP and lower levels of adiponectin. These findings are important in clinical practice because permit an earlier identification of high risk subjects.

Authors and Affiliations

R. Vasilescu, S. Ifrim, C. Ionescu-Tirgoviste, A. Muresan

Keywords

Related Articles

Treatment Of Critical Limb Ischaemia With Prostaglandins

Critical limb ischaemia is defined as ischaemic rest pain for 2 weeks or necrosis/gangrene of a toe, foot or ankle, corresponding to stages III-IV according to Fontaine classification of peripheral vascular disease. The...

CHANGES IN PHYSICAL PROPERTIES OF SKIN IN PATIENTS WITH INSUFFICIENT THERAPEUTIC CONTROLLED DIABETES MELLITUS

Cutaneous complications are common in diabetes. Previous assays suggest that hyperglycemia and decreased insulin signal/secretion are involved in the impairment of skin function. Objective: To evaluate the biophysical ch...

MONITORING THE PROGRESSION OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH DIABETIC NEPHROPATHY- A PERMANENT CHALLENGE

Aim of study – The monitoring of renal function in 2 statistically comparative groups of patients, first group with diabetic kidney disease (DKD) and the second with non-diabetics patients with the same degree of chronic...

CORRELATIONS BETWEEN PRO-INFLAMMATORY MARKERS AND GLYCATED HEMOGLOBIN IN TYPE 2 DIABETES PATIENTS

Background and Aim. Markers of inflammation are predictive of diabetic macrovascular complications. In type 2 diabetes, inflammation might be responsible for enhancing insulin resistance and may contribute to the reducti...

ACUTE PANCREATITIS IN TYPE 2 DIABETES MELLITUS – IMAGING STUDY

The inflammatory diseases of the pancreas represent an important cause of mortality worldwide and in Romania, so that making some clinical and imaging correlations between these disorders and disturbances of the carbohyd...

Download PDF file
  • EP ID EP129519
  • DOI -
  • Views 93
  • Downloads 0

How To Cite

R. Vasilescu, S. Ifrim, C. Ionescu-Tirgoviste, A. Muresan (2011). THE ASSOCIATION BETWEEN ADIPONECTIN, LEPTIN, PROINFLAMMATORY MARKERS AND METABOLIC SYNDROME IN OBESE, NONDIABETIC SUBJECTS. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 18(2), 117-129. https://europub.co.uk./articles/-A-129519